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Abstract
End-Stage Renal Disease (ESRD) is the fifth and final stage of Chronic Kidney Disease (CKD)
and has been reported to have the highest prevalence rate in the United States, with about 2,242
cases per million in the total population in 2017 (Johansen et al., 2021). Current studies
document a high prevalence of depression among patients with ESRD which may lead to
increased mortality (Shirazian et al., 2017). Additionally, barriers in access to care, which may
be understood as the barriers that prevent individuals from seeking mental health services, has
been linked to increased levels of undertreatment (Clement et al., 2012). The research linking
ESRD, and depression is clear, however, few studies document the relationship between barriers
to care and depressive symptoms. Therefore, the goals of the current study are to investigate the
relationship between barriers in access to care and depressive symptoms among patients with
ESRD, as well as the role of race/ethnicity and gender in moderating that relationship.
Identifying the relationship between barriers in access to care and depressive symptoms may
help provide direct interventions, that may improve health outcomes among patients with ESRD.

Keywords: Barriers to care, Chronic Kidney Disease (CKD), End-Stage Renal Disease
(ESRD), Depression, Depressive Symptoms.
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Barriers to Care, Depressive Symptoms, and Moderating Factors among Patients with
ESRD
Chronic Kidney Disease
According to the Center for Disease Control (CDC), approximately 15% of adults in the
United States have chronic kidney disease (CKD), and although this number has remained stable
over the past decade, the number of individuals with risk factors for CKD has risen steadily
(Johansen et al., 2021). On a global scale, the prevalence rates are similar, with about 13.4% of
the world’s population estimated to suffer from CKD (Lv & Zhang, 2019). The difference in the
global to U.S population of adults with CKD emphasizes the severity of this condition in the
U.S, with more than 1 in 7 American adults suffering from CKD (CDC, 2021).
CKD is currently defined as a significant change in kidney structure and a gradual
decrease in overall kidney function (Webster et al., 2017). This disease is primarily due to
hypertension and diabetes but other factors such as environmental toxins and infections have also
been attributed to the development of this condition (Chen et al., 2019). Currently, there is no
cure for CKD, and it is typically treated based on the stage of progression, but when left
untreated the disease may progress into full-blown kidney failure, which is known as End-Stage
Renal Disease (ESRD) (Assadi, 2021). A recent seven-year cohort study found that out of
approximately 28,779 CKD patients, 1,730 cases progressed to ESRD, and 7,628 cases ended in
death (Xie et al., 2016). Unfortunately, the bulk of the population of patients who receive little
to no care for CKD are individuals belonging to low socioeconomic status or racial/ethnic
minority groups (Xie et al., 2016).
End-Stage Renal Disease in the US
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Between 2017 and 2018, the United States Renal Data System (USRDS), reported a 2.3%
increase in the incidence of ESRD among U.S Adults. Furthermore, ESRD, which is the fifth and
final stage of CKD has been reported to have the highest prevalence rates in the United States,
with about 2,242 cases per million in the total population in 2017 (Johansen et al., 2021). The
severity of ESRD is considerably worse than CKD as it is characterized by permanent loss of
function in the kidney as well as changes in cardiovascular function, bone metabolism, and blood
coagulation (Kanda et al., 2017). For patients with ESRD, psychological effects may also include
anxiety, depression, fatigue, and reduced sleep quality (Naamani et al., 2021).
About three-quarters of patients with kidney disease are required to undergo peritoneal
(PD) or hemodialysis (HD) therapy to restore kidney function (Shrestha, 2018). Although
dialysis therapy is not preferred, it is typically used over kidney transplantation for a variety of
reasons, from lack of availability of kidney donors to failed evaluations for kidney
transplantations (Tonelli et al., 2011). Research has shown that peritoneal dialysis is the better
alternative of the two, as it is associated with reduced cost of treatments and better quality of life,
however for a variety of reasons, it is still underutilized globally (Perl & Bargman, 2016). A
2008 survey revealed that out of approximately 2 million dialysis patients, only about 10% were
given peritoneal dialysis therapy as opposed to hemodialysis (Lameire & Beisen, 2010).
Research suggests that overutilization of HD therapy is due to reduced clinical competency in
managing patients on PD (Mehrotra, 2018).
Kidney Transplantation
Despite adequate success rates associated with dialysis treatments, kidney transplantation
is still generally accepted as the best course of treatment for ESRD, due to an increase in quality
of life and overall longevity (Augustine, 2018). Kidney transplantation, which involves the
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transfer of a healthy kidney from a living or deceased donor into a recipient with kidney failure
procedure, entails multiple steps which may impact the feasibility of transplantation (i.e. the pretransplant assessment and the shortage of organ supply (Augustine, 2018). Living donor kidney
transplantation (LDKT), and deceased donor kidney transplantation (DDKT) are the two options
for kidney donation, with the latter being more common (Sigurjonsdottir & Grimm, 2019).
Research has shown that LDKT offers several advantages over DDKT, such as quicker recovery,
little to no dialysis, shorter hospital stays, and an overall bypass of the kidney transplant waitlist
(Sharma et al., 2020). Although DDKT still offers patients with kidney disease longevity after
treatment, LDKT is better correlated with higher survival rates (Sigurjonsdottir & Grimm, 2019).
This is usually because the time that deceased donor recipients spend on the waitlist equates to
more dialysis sessions, which typically projects lower survival rates post-surgery (Augustine,
2018).
In 2018, according to the United States Renal Data System (USRDS), the number of
patients with ESRD reached an all-time high of 26,726. However, the number of ESRD patients
who received a kidney transplant barely increased from the previous year. More recently, the
number of kidney transplants performed between 2019 and 2020 decreased by 2.5%, without a
decrease in the number of patients with ESRD, (United Network for Organ Sharing (UNOS),
2021). These statistics highlight the fact that although kidney transplantation is the best way to
treat kidney disease, patients may often face significant barriers before, the process of
transplantation.
Barriers in Access to Transplantation
Certain groups of patients often experience challenges in access to transplantation at
higher rates than other patients with ESRD. For the purposes of this study, these challenges will
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be referred to as the Barriers in Access to Transplantation. The most common barriers affecting
access to kidney transplantation in the United States include but are not limited to transportation,
low health literacy, lack of medical knowledge, distance from the transplant center, and
socioeconomic status (Browne et al., 2021). Researchers have found that African Americans
(AA) typically experience these challenges at higher rates than other racial groups (Harding et
al., 2017). AA represents over 30% of patients with ESRD while making up only 12.4% of the
total U.S population (Harding et al., 2017; United States Census Bureau, 2021). However, AA
are not the only minoritized group that experiences these disparities. Researchers have also found
that when compared to non-Hispanic white patients, access to transplantation is 65% lower for
AA patients and 43% lower for Hispanic/Latinx patients (Ku et al., 2020). Additionally, data
shows that of all the patients who were placed on the waiting list for a kidney transplant in 2001,
70% of white patients received a transplant while only 54% of AA and 57% of Asians received a
transplant during five years (Malek et al., 2010). These statistics show a historical trend that has
affected communities of color for decades.
In addition to race, a few studies have investigated the relationship between gender and
the barriers in access to transplantation. Some studies have come to the general conclusion that
women are less likely than men to access necessary steps in receiving a kidney transplant
(Lipford et al., 2018; Rota-Musoll et al., 2021). A longitudinal cohort study on adult ESRD
patients revealed that women were 18% less likely than men to receive activation status for
deceased donor transplantation (Garg et al., 2000). More specifically, studies have shown that
age, comorbidity, as well as the cause of kidney failure, influence the rate at which women
receive transplants relative to men (Ahearn et al., 2021; Segev et al., 2009). These trends are
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indicative of flaws in the system which influence how female patients receive treatment for
ESRD.
Psychosocial Outcomes
Current research documents the high prevalence of depression among patients with CKD
and ESRD. Moreover, the data also links the manifestation of depressive symptoms with
increased mortality and low quality of life following treatment for kidney disease (Shirazian et
al., 2017). In terms of kidney transplantation, research does document a prevalence of depressive
symptoms in this population as well. In 2014, about 25% of kidney transplantation patients
reported major depressive symptoms, with correlates of those symptoms being barriers such as
income, marital status, and malnutrition (Chilcot et al., 2014). Despite depression being most
prevalent among kidney disease patients, it is important to recognize that the assessment of
depressive symptoms among patients with kidney disease is difficult, due to an overlap between
the physical symptoms of kidney disease and depressive traits (Chilcot et al., 2008).
However, depression is not the only psychosocial outcome that can manifest from an encounter
with kidney disease and subsequent transplantation. Research has shown that despite kidney
transplantation being the safest and most effective mode of treatment for ESRD, it also provides
a difficult psychological experience that can lead to cognitive impairment, mental distress, and
varying forms of psychopathology (De Pasquale et al., 2020). Nonetheless, for the purposes of
this study, we will focus on depression as a sole psychosocial outcome. The concern for
depressive symptoms within kidney transplant patients is due to its relationship with
nonadherence to medication, mortality, graft failure, and weight gain, all of which contribute to
low quality of life (Robiner et al. 2021). The effects of psychosocial outcomes on recovery from
kidney transplantation are so dire, that it is now a standard for all adult dialysis patients to
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receive frequent evaluations for depression (Centers for Medicare & Medicaid Services, 2019).
Additionally, it is alsoa requirement that all transplant patients undergo comprehensive
psychosocial assessments before being placed on the waitlist (Mandelbrot et al., 2007).
Unfortunately, like most patients with chronic diseases, patients with ESRD experience
significant barriers in accessing mental health services that may help alleviate their symptoms.
Barriers in Access to Mental Health Care
Barriers in access to mental health care may be understood as the hurdles that prevent
individuals who display psychological symptoms such as symptoms associated with depression
and anxiety from seeking treatment, thus, leading to greater levels of undertreatment and
increased symptomology (Clement et al., 2012). These barriers are endemic in the healthcare
system today because a large percentage of people with mental health conditions avoid or delay
treatment. In the United States, about 31% of the total population suffers from anxiety and
substance use disorders and a substantial 67% never receive treatment (Clement et al., 2012).
Barriers in access to care may include but are not limited to; financial frustration, uncertainty of
where to receive help, fear of embarrassment, medical mistrust, and a fear of being involuntarily
committed, (van Beljouw et al., 2010).
Since patients diagnosed with CKD or ESRD are more likely to report psychological
distress regardless of the type of treatment they undergo (De Pasquale et al., 2020), it is clear that
barriers in access to care may play an important role in the development of these illnesses. This
position is based on research, suggesting that avoidance of treatment or lack thereof may lead to
poorer outcomes such as the development of more symptoms, poor quality of life, and an
increased possibility of remission, (Marshall et al., 2005). The barriers listed above may be
classified as stressors, which represent circumstances that force individuals to adapt to a new
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way of life and may result in psychological and/or physiological illnesses (Meyer, 2003).
Additionally, race and gender may interact with these stressors in the form of racism and sexism
to exacerbate symptoms of depression in patients with ESRD.
Theories of Race and Gender-Related Stress
Several theories have linked the relationship between minoritized statuses and increased
susceptibility to stressors, which may lead to the development of psychological symptoms. For
example, research on the minority stress model argues that individuals belonging to oppressed
groups (i.e. racial/ethnic minorities, individuals identifying as LGBTQ and/or women),
experience more incidents of stress in the form of discrimination and/or prejudice. These
incidents in turn lead to more negative health outcomes as opposed to the general population
(Meyer, 2003). More specifically, research has shown an association between sexism in the form
of subtle discrimination toward women and negative mental health outcomes, such as depression
and anxiety (Lewis, 2018). Additionally, research on the race-based traumatic stress theory
(Carter, 2007), argues that racial/ethnic minorities vulnerable to racial discrimination, are at a
higher risk for poorer physical and mental health outcomes (Polanco-Roman, Daines, & Anglin,
2016). For example, evidence suggests that discrimination and chronic stress increase the risk of
cardiovascular disease in African American women (Saban et al., 2021). This research stresses
the importance of investigating the influence of additional barriers that individuals with
minoritized statuses face that may lead to the development of physical and psychological
illnesses.
The Current Study
Although there is some research solidifying the relationship between depression and
ESRD, very few studies focus on the influence of race/ethnicity, and gender in the manifestation
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of these depressive symptoms. Some studies report barriers such as referral delays and
inadequate pretransplant evaluations as factors affecting access to renal transplantation in
African American patients (Harding et al., 2017; Nonterah & Gardiner, 2020). Furthermore,
other studies report that women are on average less likely to receive a kidney transplant than men
(Carreo et al., 2017, Lipford et al., 2018, Rota-Musoll et al., 2021). One study reported that
women have fewer conversations with their healthcare providers about kidney transplantation,
thus leading to a lower rate of transplantation (Rota-Musoll et al., 2021). However, another
study showed that women are more likely to report greater barriers in access to general
healthcare than men, due to demands on their time, income level, and childcare responsibility
(Slaunwhite, 2015). The higher number of barriers in access to care that we hypothesize may be
related to the manifestation of depressive symptoms among ESRD patients, begs the question of
why certain groups experience these symptoms more than others and how research may help
reverse this trend. Identifying and recognizing this issue could help address and prevent
depressive symptoms that may interfere with treatment and recovery from ESRD.
The research is clear that the existence or development of depression significantly affects
the success of kidney transplantation. Hence, a second perspective is presented in this paper,
theorizing that barriers in access to mental health care would exacerbate the prevalence of
depressive symptoms in patients with ESRD. Additionally, we argue that the relationship
between barriers in access to mental health care and depressive symptoms would be moderated
by race and gender (see Figure 1), since certain groups are more vulnerable to systemic
disenfranchisement due to their minoritized statuses.
Therefore, the goals of the current study were to examine the connection between barriers
in access to mental health care and depressive symptoms, as well as investigate the role that
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gender and race/ethnicity play in moderating this relationship. The primary goals of this study
are; 1.) To determine if barriers in access to care are predictive of depressive symptoms in
patients diagnosed with ESRD 2.) To determine whether race/ethnicity and gender serve as
moderating variables. It is hypothesized that the presence of multiple barriers in access to care
would predict more depressive symptoms. Additionally, race and gender would serve as
moderating variables, in which patients who identify as African American would be more likely
to experience depressive symptoms as a result of their barriers. Moreover, women would be
more likely to experience barriers in access to care and thus report higher levels of depressive
symptoms.
Methods
Recruitment
Participants were recruited from a pool of patients diagnosed with ESRD from medical
centers in the United States. Research assistants recruited participants either through letters of
invitation sent in the mail, online ads, and/or via telephone calls. Participants then consented to
participate and completed surveys that lasted about 20-30 minutes. Participants were at least 18
years of age, English speaking with the ability to comprehend study materials, and had initiated
the process to receive a kidney transplant. Participants below the age of eighteen and those who
had not expressed interest in a kidney transplant were excluded from the study. Participants were
offered $10 as gratitude for their time in the form of gift cards or money orders. This study was
approved by the University of Richmond Institutional Review Board (URIRB180506).
Participants
The surveys were completed by participants (N=77), with a mean age of 48.60 (SD=
14.47). Participants were 55.8% female (n=43), 39% male (n=30), 2.6% other (n= 2), and 1.3%
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of participants preferred not to respond (n=1). Data from the few participants who did not
identify as male or female was not used in the between-group analyses because the sample was
too small. Additionally, participants were 46.8% African American (n= 36), 50.6% White
(n=39), 1.3% Native American/Alaskan (n= 1), 1.3% Middle Eastern/North African (n= 1),
1.3% Hispanic/Latinx (n= 1), 3.9% mixed race (n= 3), and 1.3% other (n=1). Data from the few
participants who did not identify as African American or White was not used in the betweengroup analyses because the sample was too small.
Materials and Measures
Data obtained from the completed surveys focused on the experiences of ESRD patients
who had experienced barriers in accessing transplantation. The current study is part of a larger
study entitled, The Development of the Barriers in Access to Transplantation Scale. Measures
completed included; the Patient Health Questionnaire (PHQ), Health Literacy Questionnaire
(HLQ), Rapid Estimate of Adult Literacy in Medicine – Transplantation (REAL-T), Barriers in
Access to Transplant Scale (BATS), and the Barriers to Access to Care Evaluation scale (BACE
v3). This study focuses on demographic measures, the Patient Health Questionnaire (PHQ), and
the Barriers to Access to Care Evaluation scale (BACE v3).
Additionally, demographic information such as race, gender, age, employment status,
annual income level, sexual orientation, disability status, relationship status, health insurance,
and religion was collected.
The Barriers in Access to Care Evaluation (BACEv3). This instrument was initially
created to provide evidence on the existence of specific barriers that adults with mental illness
face when trying to access mental health services (BACEv3; Clement & Thornicroft, 2011). The
survey contained 30 separate item questions. The questions on the survey include 12 items
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assessing stigma-related barriers, which measure the extent to which stigma and discrimination
serve as barriers to care. Stigma-related items on the questionnaire include but are not limited to
“Wanting to solve the problem on my own.” Eight items assess non-stigma-related barriers. A
sample question is, “Being unsure of where to go to get professional care.” Ten items assess
altitudinal-related barriers, which represent personal beliefs about the illness. A sample question
is, “Preferring to get help from family or friends” (Clement & Thornicroft, 2011). Participant
responses were measured on a Likert-type scale as response scores ranged from 0 (This is NOT
APPLICABLE to me,) to 5 (“this has stopped, delayed, or discouraged me A LOT “). Summed
scores for the BACE range from 0-90, therefore during analysis responses were recoded into
different variables, changing it from 0-5 to 0-3. The responses, not applicable and Not Sure were
removed from the scale. The BACE v3 scale has strong internal consistency (α = 0.90) and testretest reliability (r = 0.92) (Clement et al., 2012). For the current study, α =0.97 for the total
scale, α =0.95 for the stigma subscale, α =0.83 for the non-stigma subscale, and, α =0.87 for the
attitudinal subscale.
The Patient Health Questionnaire (PHQ). This measure was used to assess patientreported symptoms of depression. It was initially created to assess and diagnose adult patients
with depression in primary care settings (Kroenke, Spitzer, and Williams, 2001). The current
study uses this scale to identify the presence of depressive symptoms among kidney transplant
patients. The PHQ consists of 9 separate item questions and sum scores from the PHQ may range
from 0 to 27, as each of the 9 questions are scored on a Likert type scale, from 0 (not at all) to 3
(nearly every day) (Kroenke, Spitzer, and Williams, 2001). Items on the questionnaire include
but are not limited to: “Feeling down, depressed or hopeless”, and “Little interest or pleasure in
doing things.” The PHQ has strong internal consistency (α = 0.89) and test-retest reliability

BARRIERS IN ACCESS TO CARE AND DEPRESSION

14

(r = 0.84) (Kroenke, Spitzer, and Williams, 2001). The current study had a Cronbach’s alpha of
0.90 for the 9 items on the PHQ-9.
Results
Data Analytic Plan
Data from survey results were collected via Qualtrics and transferred to the statistical
software program, IBM Statistical Package for the Social Sciences (SPSS) for analyses.
ANOVAs, correlations, and regressions were used to examine the key hypotheses, including the
appropriate assumptions.
Descriptive Statistics
Descriptive statistics, including means and standard deviations, were conducted on the
demographic information. Participants were predominantly white (50.6%) and female (55.8%)
with an average age of 48.60 (SD= 14.47). Most also had an annual household income of less
than 60,000 (49.4%) and a high school education or less (28.6%), (see Table 1. For more details).
Main Analyses
Hypothesis 1 was supported by the results of a simple regression. Depressive
symptoms as measured by the PHQ scale had a significant positive correlation with Barriers in
Access to Care with a small effect size (r = .173, p = .002). Depressive symptoms also had a
significant positive correlation with stigma-related, attitudinal related, and the non-stigma related
barriers in access to care (r= .166, p = .004; r= .221. p= .001; r= .155 p= .005).
Hypotheses 2 could not be tested, as the data violated the sample size assumption for a
multiple regression. Tabachnick & Fidell (2007), provide a formula for determining sample size
requirement: N> 50 +8m (m= independent variable). Only n=54 participants had complete data.
The formula requires at least N ≥ 74 participants.
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However, data analysis did reveal differences in participant responses based on race and
gender. A one-way ANOVA revealed that there was a statistically significant difference in
overall BACE scores, BACE attitudinal scores, and BACE non-stigma scores between African
American and white participants (F (1,49) =4.710, p= .035; F (1,46) =4.654, p= .036; F (1,44) =
4.899, p= 0.32). The Levene’s F test revealed that the homogeneity of variance assumption was
met in each case (p =.276; p= .326; p= .225). White participants averaged (M= 32.22, SD=
26.92) higher scores on the BACE compared to African Americans (M= 17.20, SD= 21.82).
White Participants also averaged (M=11.46, SD= 9.34; M= 10.21, SD= 6.37) higher scores on
the BACE attitudinal and non-stigma treatment scales compared to African Americans (M= 6.05,
SD= 7.79; M= 6.18, SD= 5.92). Additionally, a one-way ANOVA did not reveal a statistically
significant difference in BACE treatment stigma scores between African American and white
participants (F (1,45) = 2.291, p= .137). “Levene’s test showed that the variances for BACE
treatment stigma scores between African American and white participants was equal., F (1,45) =
.812 p = .372. There was no significant effect for gender in overall BACE scores, BACE
attitudinal scores, BACE treatment stigma scores, and BACE non-stigma scores (F (1,53) = .102,
p= .750; F (1,50) = .088, p= 0.768); F (1,49) = .285, p= .596; F (1,48) = .105, p= 0.747). The
Levene’s F test revealed that the homogeneity of variance assumption was met in each case (p
=.323; p= .352; p= .467; p= .720).
In measuring depressive symptoms, a one-way ANOVA did not reveal a statistically
significant difference in PHQ scores between African American and White participants, F (1,56)
= .548, p= .462). There was no significant effect for gender in PHQ scores, (F (1,61)) = .027,
p=.871). Of note, the Levene’s F test revealed that the homogeneity of variance assumption was
met for race but not for gender (p= .308; p = .005).
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Discussion
The focus of the current study was to investigate the relationship between barriers in
access to care and depressive symptoms in patients with ESRD. Additionally, the study
examined race/ethnicity and gender as factors that may exacerbate this relationship. Consistent
with research that documents the high prevalence of depression among patients with kidney
disease (Shirazian et al., 2017), as well as studies that document race/ethnicity and gender
disparities within access to care, the following hypothesis (H) were developed. H1: There would
be a relationship between barriers in access to care and depressive symptoms. H2:
Race/Ethnicity and gender would serve as moderating variables in the relationship between
barriers in access to care and depressive symptoms
Overall, data analysis among the current sample of patients with ESRD suggest that there
is an association between barriers in access to mental health care and depressive symptoms.
Thus, providing support for hypothesis 1. This data suggests that as the number of barriers in
access to care increases, the likelihood of manifesting depressive symptoms increases as well.
Results of the current study are consistent with findings from past research. Depression in
patients with ESRD has been found to have correlates with both psychological and demographic
predictors such as, social support, illness beliefs, coping styles, low income, employment status,
and education (Chilcot et al., 2014; Tsunoda et al., 2010)
Additionally, the results of the study also indicate that in the current sample of patients
with ESRD, attitudinal., non-stigma, and treatment-stigma-related barriers were also related to
depressive symptoms among patients with ESRD. This data suggests that regardless of the type
of barriers that are present, there is still a likelihood of the manifestation of depressive

BARRIERS IN ACCESS TO CARE AND DEPRESSION

17

symptoms. Therefore, patients with multiple attitudinal., non-stigma, and/or stigma-related
barriers are still likely to have depressive symptoms.
Hypothesis 2 could not be tested as it violated the sample size assumption for multiple
regressions. However, further analysis on differences in race/ethnicity on depressive symptoms
did reveal differences among participants' responses. Results of the analyses revealed that white
participants on average significantly had more barriers in access to care than African American
participants. These results hold for both the attitudinal and non-stigma related items on the
BACE survey but not the stigma-related items. The data suggests that although White
participants experience more barriers in access to care as opposed to African Americans, a
majority of the barriers they experience were either due to personal attitudes or instrumental
factors (i.e. relating to financial constraints or systemic factors). Those barriers were not related
to forms of stigma such as discrimination and prejudice that are commonly experienced by
African Americans.
Findings from the current study, that White patients experience more barriers in access to
care than African Americans, do not align with findings from previous studies. Cook et al.
(2016), found that between 2004 and 2012 disparities in access to mental health care
significantly increased among African Americans as opposed to Whites. However, results from
our study may be explained by the possibility that African Americans in this sample may have
not been seeking mental health services specifically, as they were focused on barriers to
accessing kidney transplantation. There were no significant gender differences in barriers in
access to care experienced among participants. Additionally, analysis did not reveal any
significant gender or racial differences in the average number of depressive symptoms.
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According to the present study, the number of barriers in access to care and the number
of depressive symptoms among patients with ESRD are connected. Therefore, barriers in access
to care influence the manifestation of depressive symptoms. Studies suggest that the presence of
depression among ESRD patients is related to increased hospitalization rates, mortality rates, and
reduced quality of life (Molnar et al., 2017; Shirazian et al., 2017). Furthermore, a study showed
that patients with ESRD and depression undergoing hemodialysis therapy are two times as likely
to die or be hospitalized compared to ESRD patients without depression (Hedayati, Yalamanchili
& Finkelstein, 2012). Therefore, implications from this study signify that the association
established between barriers in access to care and depressive symptoms is important, as it
highlights a potential remedy for mitigating a comorbid diagnosis of ESRD and depression.
It is important to recognize the presence of limitations in the current study. Firstly, the
small sample size is a significant limitation to the study’s methods. Not only does the sample
size reduce the power of the study and its generalizability, but the moderation analysis also could
not be conducted. Additionally, there were limited categories of race/ethnicity and gender for
participant responses. Therefore, all analyses were limited to African American vs White and
female vs male response data. Furthermore, participant data was collected through self-report
measures. Data collected through self-report measures may present the issue of the social
desirability response bias which causes participants to report experiences that are considered to
be socially acceptable or preferred. This is consistent with research that argues that the social
desirability response bias may cause inaccurate responses (Latkin et al., 2017).
Unfortunately, we were not able to determine the role of race/ethnicity and gender, but
this does not mean that there are no hidden disparities within barriers in access to care, that may
disproportionately affect individuals with marginalized identities. Therefore, future research
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aimed at investigating the role of race/ethnicity and gender as moderators in the relationship
between barriers in access to care and depressive symptoms should use a larger sample size.
Researchers should also focus on recruiting a more inclusive and diverse sample of patients that
accounts for more than one minoritized group, as well as address the difficulties associated with
recruiting ESRD patients (i.e., lack of cultural training, and mistrust in research). Lastly,
researchers should also investigate the role of other factors (i.e., income, employment status, and
health insurance) as possible moderators of that relationship.
Research has addressed the relationship between depression and ESRD, as well as how
depression negatively affects treatment of ESRD. However, research is yet to address the
relationship between barriers in access to care and depressive symptoms among ESRD patients.
The findings from this study shed light on the role that barriers in access to care play in the
manifestation of these symptoms. Therefore, the association between barriers to care and
depressive symptoms found in this study, suggest the need to screen for barriers to care among
patients with ESRD or CKD. Identifying and eliminating these barriers may be useful in
reducing the prevalence of depressive symptoms among this population. Lastly, results from this
study may help formulate further research and stresses the need to develop interventions to
reduce barriers in access to care. Possible interventions such as; increasing community outreach
efforts, expanding telehealth, prioritizing the use of simple language, and increased awareness
about the severity of psychological conditions, may help reduce the prevalence of depressive
symptoms, which may then lead to more positive health outcomes for patients with ESRD.
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Figure 1.
Moderating Model for Barriers in Access to Mental Health Care and Depressive Symptoms with
race/ethnicity and gender.
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Table 1.
Sample Characteristics
Variable
Age
Race/Ethnicity
African American
White
Hispanic/Latinx
Middle Eastern/Northern African
Native American/Alaskan
Other
Gender
Male
Female
Other
NR/NA
Annual Household Income
0 -19,999 7 (23.3)
20,000 -39,999
40,000 -59,999
60,000 -79,999
80,000 -99,999
100,000+
NR/NA
Don’t Know
Education
High School or less
Associates Degree
Some college, no degree
More than an Associate’s Degree, but no
Bachelor’s degree
Bachelor’s degree
Some graduate, no degree
Master’s degree
Doctorate
NA/NR
Employment Status
Student, full time
Student, part-time
Employed, full time
Unemployed, on disability
Unemployed, supported by family
Unemployed, supported by other
NA/NR

Whole Sample
(N = 77)
(M= 48.60, SD =14.47)
36 (46.8%)
39 (50.6%)
1 (1.3%)
1 (1.3%)
1 (1.3%)
1 (1.3%)
30 (39.0%)
43 (55.8%)
2 (2.6%)
1 (1.3%)
22 (28.6%)
11 (14.3%)
6 (7.8%)
12 (15.6%)
8 (10.4%)
9 (11.7%)
7 (9.1%)
1 (1.3%)
22 (28.6%)
3 (3.9%)
17 (22.1%)
1 (1.3%)
14 (18.2%)
5 (6.5%)
10 (13%)
1 (1.3%)
2 (2.6%)
13 (16.9%)
21 (27.3%)
8 (10.4%)
17 (22.1%)
1 (1.3%)
10 (13%)
2 (2.6%)

30

